195 related articles for article (PubMed ID: 27028872)
1. Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and Isolated Phospholipases A2 by Specific Camelid Single-Domain Antibody Fragments.
Prado ND; Pereira SS; da Silva MP; Morais MS; Kayano AM; Moreira-Dill LS; Luiz MB; Zanchi FB; Fuly AL; Huacca ME; Fernandes CF; Calderon LA; Zuliani JP; Pereira da Silva LH; Soares AM; Stabeli RG; Fernandes CF
PLoS One; 2016; 11(3):e0151363. PubMed ID: 27028872
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of sulfated fucose branches in fucosylated chondroitin sulfate are essential for the polysaccharide effect preventing muscle damage induced by toxins and crude venom from Bothrops jararacussu snake.
Monteiro-Machado M; Tomaz MA; Fonseca RJ; Strauch MA; Cons BL; Borges PA; Patrão-Neto FC; Tavares-Henriques MS; Teixeira-Cruz JM; Calil-Elias S; Cintra AC; Martinez AM; Mourão PA; Melo PA
Toxicon; 2015 May; 98():20-33. PubMed ID: 25702961
[TBL] [Abstract][Full Text] [Related]
3. Linear B-cell epitopes in BthTX-1, BthTX-II and BthA-1, phospholipase A₂'s from Bothrops jararacussu snake venom, recognized by therapeutically neutralizing commercial horse antivenom.
De-Simone SG; Napoleão-Pego P; Teixeira-Pinto LA; Santos JD; De-Simone TS; Melgarejo AR; Aguiar AS; Marchi-Salvador DP
Toxicon; 2013 Sep; 72():90-101. PubMed ID: 23792452
[TBL] [Abstract][Full Text] [Related]
4. Development of Nanobodies Against Hemorrhagic and Myotoxic Components of
Bailon Calderon H; Yaniro Coronel VO; Cáceres Rey OA; Colque Alave EG; Leiva Duran WJ; Padilla Rojas C; Montejo Arevalo H; García Neyra D; Galarza Pérez M; Bonilla C; Tintaya B; Ricciardi G; Smiejkowska N; Romão E; Vincke C; Lévano J; Celys M; Lomonte B; Muyldermans S
Front Immunol; 2020; 11():655. PubMed ID: 32457735
[TBL] [Abstract][Full Text] [Related]
5. Alkylation of histidine residues of Bothrops jararacussu venom proteins and isolated phospholipases A2: a biotechnological tool to improve the production of antibodies.
Guimarães CL; Andrião-Escarso SH; Moreira-Dill LS; Carvalho BM; Marchi-Salvador DP; Santos-Filho NA; Fernandes CA; Fontes MR; Giglio JR; Barraviera B; Zuliani JP; Fernandes CF; Calderón LA; Stábeli RG; Albericio F; da Silva SL; Soares AM
Biomed Res Int; 2014; 2014():981923. PubMed ID: 24901004
[TBL] [Abstract][Full Text] [Related]
6. Cross-neutralization of the neurotoxicity of Crotalus durissus terrificus and Bothrops jararacussu venoms by antisera against crotoxin and phospholipase A2 from Crotalus durissus cascavella venom.
Beghini DG; da Cruz-Höfling MA; Randazzo-Moura P; Rodrigues-Simioni L; Novello JC; Hyslop S; Marangoni S
Toxicon; 2005 Nov; 46(6):604-11. PubMed ID: 16157360
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of single domain antibody efficacy in mitigating local tissue damage induced by Bothrops snake envenomation.
Dantas Reis Prado N; Brilhante-DA-Silva N; Valentino Paloschi M; Andrade Roberto S; Cardim Barreto B; Fraga Vasconcelos J; Botelho Pereira Soares M; Monteiro de Carvalho R; Foschiera de Melo T; de Souza Santos E; Lima Dos Santos E; Eugenia Souza de Jesus B; Crhistina Santos de Araújo E; Martins Soares A; Guerino Stabeli R; Freire Celedonio Fernandes C; Pavan Zuliani J; Dos Santos Pereira S
Int Immunopharmacol; 2024 Jun; 134():112215. PubMed ID: 38744173
[TBL] [Abstract][Full Text] [Related]
8. Human antibody fragments specific for Bothrops jararacussu venom reduce the toxicity of other Bothrops sp. venoms.
Roncolato EC; Pucca MB; Funayama JC; Bertolini TB; Campos LB; Barbosa JE
J Immunotoxicol; 2013; 10(2):160-8. PubMed ID: 22954026
[TBL] [Abstract][Full Text] [Related]
9. BthTX-II from Bothrops jararacussu venom has variants with different oligomeric assemblies: An example of snake venom phospholipases A
Borges RJ; Salvador GHM; Campanelli HB; Pimenta DC; de Oliveira Neto M; Usón I; Fontes MRM
Int J Biol Macromol; 2021 Nov; 191():255-266. PubMed ID: 34547312
[TBL] [Abstract][Full Text] [Related]
10. Preliminary X-ray crystallographic studies of BthTX-II, a myotoxic Asp49-phospholipase A2 with low catalytic activity from Bothrops jararacussu venom.
Corrêa LC; Marchi-Salvador DP; Cintra AC; Soares AM; Fontes MR
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Aug; 62(Pt 8):765-7. PubMed ID: 16880551
[TBL] [Abstract][Full Text] [Related]
11. Myotoxic phospholipases A(2) in bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu.
Andrião-Escarso SH; Soares AM; Rodrigues VM; Angulo Y; Díaz C; Lomonte B; Gutiérrez JM; Giglio JR
Biochimie; 2000 Aug; 82(8):755-63. PubMed ID: 11018293
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of the pharmacological effects of bothropstoxin-I from Bothrops jararacussu (jararacuçu) venom by crotoxin antiserum and heparin.
Oshima-Franco Y; Leite GB; Silva GH; Cardoso DF; Hyslop S; Giglio JR; da Cruz-Höfling MA; Rodrigues-Simioni L
Toxicon; 2001 Oct; 39(10):1477-85. PubMed ID: 11478955
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the myotoxic activity of Bothrops jararacussu venom and its two major myotoxins, BthTX-I and BthTX-II, by the aqueous extract of Tabernaemontana catharinensis A. DC. (Apocynaceae).
Veronese EL; Esmeraldino LE; Trombone AP; Santana AE; Bechara GH; Kettelhut I; Cintra AC; Giglio JR; Sampaio SV
Phytomedicine; 2005 Jan; 12(1-2):123-30. PubMed ID: 15693719
[TBL] [Abstract][Full Text] [Related]
14. Muscle proteolysis via ubiquitin-proteasome system (UPS) is activated by BthTx-I Lys49 PLA
Kenzo-Kagawa B; Vieira WF; Cogo JC; da Cruz-Höfling MA
Toxicol Appl Pharmacol; 2020 Sep; 402():115119. PubMed ID: 32619552
[TBL] [Abstract][Full Text] [Related]
15. Fractionation of Bothrops jararacussu snake venom: partial chemical characterization and biological activity of bothropstoxin.
Homsi-Brandeburgo MI; Queiroz LS; Santo-Neto H; Rodrigues-Simioni L; Giglio JR
Toxicon; 1988; 26(7):615-27. PubMed ID: 3176051
[TBL] [Abstract][Full Text] [Related]
16. Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom.
Tamarozzi MB; Soares SG; Marcussi S; Giglio JR; Barbosa JE
Biochim Biophys Acta; 2006 Sep; 1760(9):1450-7. PubMed ID: 16828972
[TBL] [Abstract][Full Text] [Related]
17. Renal and antibacterial effects induced by myotoxin I and II isolated from Bothrops jararacussu venom.
Barbosa PS; Martins AM; Havt A; Toyama DO; Evangelista JS; Ferreira DP; Joazeiro PP; Beriam LO; Toyama MH; Fonteles MC; Monteiro HS
Toxicon; 2005 Sep; 46(4):376-86. PubMed ID: 16115661
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing capacity of commercial bothropic antivenom against Bothrops jararacussu venom and bothropstoxin-I.
Oshima-Franco Y; Hyslop S; Cintra AC; Giglio JR; da Cruz-Höfling MA; Rodrigues-Simioni L
Muscle Nerve; 2000 Dec; 23(12):1832-9. PubMed ID: 11102906
[TBL] [Abstract][Full Text] [Related]
19. Different effects of myotoxins bothropstoxin-I and II from Bothrops snake venom on cation transport ATPases from murine fast twitch skeletal muscle.
Ayres R; Feijó PR; Cintra AC; Tomaz MA; Melo PA; Cunha VM; Quintas LE
Toxicon; 2015 Sep; 103():80-4. PubMed ID: 26091877
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of a phospholipase A
Salvador GH; Dos Santos JI; Lomonte B; Fontes MR
Biochimie; 2017 Feb; 133():95-102. PubMed ID: 28034717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
